Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment
Bibliographic Data
| ID | 14907465 |
|---|---|
| Authors | Nathalie Scherz (0000-0003-2824-6056, University Hospital of Zurich), Philip Bruggmann (0000-0002-0436-8895, Addiction Switzerland, corresponding author), Nathalie Brunner (0000-0002-7559-1269, Addiction Switzerland) |
| Year | 2018 |
| Volume | 62 |
| Pages | 74-77 |
| Publication date | 2018-12-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2018.10.003 |
| PMID | 30368101 |
| OpenAlex | W2898404742 |
| Language | EN |
| Citations received | 4 |
| References cited | 13 |
Drug · Hepatitis C · Hepatitis C virus · Heroin · Population · Virus · Alcohol Consumption and Health Effects · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Immunology · Internal Medicine · Pharmacology
An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use
Integrated models of care for people who inject drugs and live with hepatitis C virus
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland
| Citations per year | 0.57 |
|---|---|
| Citation span | 2019 - 2023 (5) |
| Highly cited | No |